On June 13th, Jessica Moran, Strainprint Director of Marketing & Communications appeared on the Humble & Fred Radio show where she talked about Strainprint’s O’Cannabiz sponsorship, and the use of medical cannabis as a viable therapeutic option.
On June 7-9th Strainprint participated in O’Cannabiz as a platinum sponsor. The weekend was filled with insightful panels, productive industry discussions, and invaluable networking! Have a look at our round-up from the action-packed weekend below! We look foward to next year!
On Wednesday, July 11th, 2018 Strainprint President & CTO, David Berg, and COO of Emblem Cannabis Corp, Adam Saperia had the opportunity to appear on the Humble & Fred Radio show where they talked about the benefits of medical cannabis, patient tracking and how data is helping to shape the future of the cannabis industry.
On July 10th, 2018 Strainprint had the opportunity to participate in CannabisFest where our Founder, Stephanie Karasick participated in an AMA focused on how Entrepreneurs can prepare for legalization. https://betakit.com/cannabisfest-explores-how-entrepreneurs-can-prepare-for-legalization/
Recently, Strainprint Founder Stephanie Karasick was featured in The Growth Op. Here she talks about the launch of the Strainprint app that helped, and continues to help her and tens of thousands of other patients keep track of their medical marijuana dosage. Read more about Steph’s journey, and Strainprint here: https://www.thegrowthop.com/cannabis-business/cannabis-experts/when-it-comes-to-cannabis-prescriptions-sometimes-less-is-more
We are proud to present the genesis of Strainprint. Steph’s story is what defines us. With her story, and 1,000’s more like it we will continue to break the stigma & pave the way for the future of the cannabis industry. Have a look at Steph’s story, and if it resonates with you, consider sharing! […]
TORONTO, May 8, 2018 /PRNewswire/ – StrainprintTM Technologies — the leader in cannabis data and analytics is pleased to announce the closing of a USD $3 Million (Cdn.$3.8 Million) non-brokered, Series A private placement. The round was led by strategic industry investor, Cesare Fazari, Chairman of Molecular Science Corp and seed investor of leading cannabis companies, Ample Organics and Hydropothecary. Mr. Fazari […]
PULLMAN, WA – In a first-of-a-kind study, Washington State University scientists examined how peoples’ self-reported levels of stress, anxiety and depression were affected by smoking different strains and quantities of cannabis at home. Their work, published this month in the Journal of Affective Disorders, suggests smoking cannabis can significantly reduce short-term levels of depression, anxiety, […]
Dr. Caroline MacCallum, Dr. Danial Schecter & Dr. Dean Elterman Join Strainprint’s World-Class Medical Advisory Board TORONTO, April 17, 2018 /CNW/ – Strainprint, the leader in cannabis data & analytics, is pleased to announce that Dr. Caroline MacCallum, Dr. Danial Schecter and Dr. Dean Elterman have joined its Board of Medical Advisors. Strainprint works closely […]